Calamos Advisors »

Arcutis Biotherapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6M 54k 29.04

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Western Digital Corp Note 3.000%11/1 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
D. E. Shaw & Co
Ensign Peak Advisors
Franklin Resources

View all funds holding Arcutis Biotherapeutics